Since the pro-tumorigenic role of the CCR2/CCL2 axis has been widely reported in breast cancer28,29,32,47,55, we looked to test the combination therapy in a breast cancer model utilizing the E0771 cell line, which was originally derived from a spontaneous mammary tumor in a female C57BL/6 mouse56. Here, CCR2 is linked to breast carcinoma.